Agenda and Presentations | Inozyme Pharma Inc.

Welcome

Axel Bolte, MBA
Co-Founder, President and Chief Executive Officer, Inozyme Pharma
Watch Replay

ENPP1 Deficiency

ENPP1 Deficiency Overview
Watch Replay

Michael Levine, M.D.
Professor Emeritus, Pediatrics and Medicine and Chief Emeritus, Division of Endocrinology and Diabetes at the Center for Bone Health at the Children’s Hospital of Philadelphia Research Institute

ENPP1 Deficiency Phase 1/2 Clinical Trial Data
Watch Replay

Yves Sabbagh, Ph.D.
Senior Vice President and Chief Scientific Officer, Inozyme Pharma

Kurt Gunter, M.D.
Senior Vice President and Chief Medical Officer, Inozyme Pharma

David Thompson, M.A, M.S., Ph.D.
Senior Advisor, Member of Scientific Advisory Board, Inozyme Pharma

ENPP1 Deficiency Regulatory Strategy
Watch Replay

Kurt Gunter, M.D.
Senior Vice President and Chief Medical Officer, Inozyme Pharma

ABCC6 Deficiency

ABCC6 Deficiency Disease Overview
Watch Replay

Wilko Spiering, M.D., Ph.D.
Associate Professor, Division of Internal Medicine and Dermatology, Department of Vascular Medicine, at the University Medical Center Utrecht of Utrecht University

ABCC6 Deficiency Phase 1/2 Clinical Trial Data
Watch Replay

Yves Sabbagh, Ph.D.
Senior Vice President and Chief Scientific Officer, Inozyme Pharma

Kurt Gunter, M.D.
Senior Vice President and Chief Medical Officer, Inozyme Pharma

ABCC6 Deficiency Regulatory Strategy
Watch Replay

Kurt Gunter, M.D.
Senior Vice President and Chief Medical Officer, Inozyme Pharma

ENPP1 Deficiency Prevalence Update

Mark Kiel, M.D., Ph.D.
Chief Science Officer, Genomenon
Watch Replay

Commercial Strategy

Henric Bjarke
Senior Advisor, Inozyme Pharma
Watch Replay

Financial Guidance and 2023 Milestones

Sanjay Subramanian, M.S., MBA
Senior Vice President and Chief Financial Officer, Inozyme Pharma
Watch Replay

Question & Answer Session